0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Cancer Biomarkers
 1-20 of 256 Articles
JAMA Oncology | 
Editorial |  ONLINE FIRST
Nicole J. Gormley, MD; Ann T. Farrell, MD; Richard Pazdur, MD
JAMA Oncol. Published online September 15, 2016. doi:10.1001/jamaoncol.2016.3112

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Nikhil C. Munshi, MD; Herve Avet-Loiseau, PhD; Andy C. Rawstron, PhD; et al.
JAMA Oncol. Published online September 15, 2016. doi:10.1001/jamaoncol.2016.3160
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
E. Shannon Story, MD, FACE; Edward S. Kim, MD, FACP
JAMA Oncol. Published online September 01, 2016. doi:10.1001/jamaoncol.2016.3286

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Rengyun Liu, PhD; Justin Bishop, MD; Guangwu Zhu, BS; et al.
JAMA Oncol. Published online September 01, 2016. doi:10.1001/jamaoncol.2016.3288
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Surein Arulananda, MBBS; Thomas John, MBBS, PhD, FRACP
JAMA Oncol. Published online September 01, 2016. doi:10.1001/jamaoncol.2016.2854

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Peter W. Szlosarek, MD, PhD; Jeremy P. Steele, MD; Luke Nolan, MD, PhD; et al.
JAMA Oncol. Published online September 01, 2016. doi:10.1001/jamaoncol.2016.3049
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Axel Grothey, MD; Daniel J. Sargent, PhD
JAMA Oncol. 2016;2(9):1133-1134. doi:10.1001/jamaoncol.2016.2304.

JAMA Oncology | 
Original Investigation | 
Nan Song, PhD; Katherine L. Pogue-Geile, PhD; Patrick G. Gavin, BS; et al.
JAMA Oncol. 2016;2(9):1162-1169. doi:10.1001/jamaoncol.2016.2314.
Includes: Supplemental Content

JAMA Oncology | 
Review | 
Adrian G. Sacher, MD; Leena Gandhi, MD, PhD
JAMA Oncol. 2016;2(9):1217-1222. doi:10.1001/jamaoncol.2016.0639.

JAMA Oncology | 
Review |  ONLINE FIRST
Polly Niravath, MD; Burcu Cakar, MD; Matthew Ellis, MB, BChir, PhD, FRCP
JAMA Oncol. Published online August 25, 2016. doi:10.1001/jamaoncol.2016.2719

JAMA Surgery | 
Original Investigation |  ONLINE FIRST
Felice Giuliante, MD; Francesco Ardito, MD; Alfredo Guglielmi, MD; et al.
JAMA Surg. Published online August 24, 2016. doi:10.1001/jamasurg.2016.1769
Includes: Supplemental Content

JAMA Oncology | 
Brief Report |  ONLINE FIRST
Patricia Gaule, PhD; James W. Smithy, BS; Maria Toki, MD; et al.
JAMA Oncol. Published online August 18, 2016. doi:10.1001/jamaoncol.2016.3015
Includes: Supplemental Content

JAMA Dermatology | 
Original Investigation |  ONLINE FIRST
Nathaniel H. Fleming, BA; Barbara M. Egbert, MD; Jinah Kim, MD, PhD; et al.
JAMA Dermatol. Published online August 17, 2016. doi:10.1001/jamadermatol.2016.2869

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Suzanne A. W. Fuqua, PhD; Yassine Rechoum, PhD; Guowei Gu, PhD
JAMA Oncol. Published online August 11, 2016. doi:10.1001/jamaoncol.2016.1268

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Sarat Chandarlapaty, MD, PhD; David Chen, PhD; Wei He, PhD; et al.
JAMA Oncol. Published online August 11, 2016. doi:10.1001/jamaoncol.2016.1279
Includes: Supplemental Content

JAMA Oncology | 
Review |  ONLINE FIRST
Krijn K. Dijkstra, MD; Paula Voabil, MSc; Ton N. Schumacher, PhD; et al.
JAMA Oncol. Published online August 04, 2016. doi:10.1001/jamaoncol.2016.2214

JAMA Oncology | 
Viewpoint |  ONLINE FIRST
Yu Zhang, MD; Lieping Chen, MD, PhD
JAMA Oncol. Published online August 04, 2016. doi:10.1001/jamaoncol.2016.2450

JAMA Oncology | 
Invited Commentary | 
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncol. 2016;2(8):1037-1039. doi:10.1001/jamaoncol.2016.0283.

JAMA Oncology | 
Research Letter | 
David Liu, MD, MPH, MS; Elizabeth R. Plimack, MD, MS; Jean Hoffman-Censits, MD; et al.
JAMA Oncol. 2016;2(8):1094-1096. doi:10.1001/jamaoncol.2016.1056.

JAMA Dermatology | 
Brief Report | 
John Charles Rotondo, PhD; Alessandro Borghi, MD; Rita Selvatici, PhD; et al.
JAMA Dermatol. 2016;152(8):928-933. doi:10.1001/jamadermatol.2016.1336.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editorial  | 
Minimal Residual Disease as a Potential Surrogate End Point—Lingering Questions
Nicole J. Gormley, MD; Ann T. Farrell, MD; Richard Pazdur, MD
JAMA Oncology
Original Investigation  | 
Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma A Meta-analysis
Nikhil C. Munshi, MD; Herve Avet-Loiseau, PhD; Andy C. Rawstron, PhD; et al.
JAMA Oncology
Editorial  | 
Adjuvant Therapy for Colon Cancer Small Steps Toward Precision Medicine
Axel Grothey, MD; Daniel J. Sargent, PhD
JAMA Oncology
Original Investigation  | 
Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial
Nan Song, PhD; Katherine L. Pogue-Geile, PhD; Patrick G. Gavin, BS; et al.